Recent News
Powered by Alpha Vantage
No recent news found.
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot
Sinovac Biotech Ltd., a biopharmaceutical company, focuses on the research, development, manufacture and marketing of vaccines against human infectious diseases in the People's Republic of China. The company is headquartered in Beijing, the People's Republic of China.
52W High
$6.47
52W Low
$6.47
MA Status:
50D: Below
200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.06
Valuation
Attractive
As of 2023-12-31 (Overview)
Trailing P/E (<15 better)
6.66
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
0.04
EV/Revenue (<3 favorable)
0.03
P/S (TTM) (<3 favorable)
1.83
P/B (<3 favorable)
1.82
Ownership
BalancedSource: Overview
Insiders (1–5% typical)
51.42%
Institutions (25–75% balanced)
32.03%
Shares Outstanding
99,295,000
Float
59,508,000
Dividend Yield (2–6% sweet spot)
8.50%
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2023-12-31 (Overview)
Revenue (TTM)
510,624,000
Gross Profit (TTM)
443,444,000
EPS (TTM)
0.97
Profit Margin (>10% good)
0.22%
Operating Margin (TTM) (higher better)
0.42%
ROE (TTM) (>15% strong)
0.25%
EPS YoY (Quarterly) (>10% good)
3.55
Revenue YoY (Quarterly) (>8% good)
3.04
Momentum
Bearish momentumValue
0.1436
Previous
0.1550
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025